Default sprint speed increased from 0.5 to 1.0. - Sprint disable duration reduced ... Improved timing of sever lag compensation to engage during the first phase of bullet creation which previously ...

March 13, 2025 /PRNewswire/ -- Third Arc Bio Inc., a clinical stage biotech ... T cell engager targeting Claudin 6 (CLDN6). This Phase 1 study will evaluate the optimal dosing, safety ...

SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of GPCR drug discovery, today announced ...

President Donald Trump's envoy to the Middle East, Steve Witkoff, said Sunday that he would aim to negotiate an "extension" of Phase One of the Israel-Hamas hostage release and ceasefire deal when ...

They are believed to be the final living hostages scheduled for release in the current first phase of the deal, with only four more hostages, all believed to be dead, set for release on Thursday.

Nestled on a generous 801sqm block, this charming 3-bedroom, 1-bathroom home offers a welcoming atmosphere with multiple living areas, a renovated kitchen, and a sunken formal lounge with reverse ...

March 13, 2025 /PRNewswire/ -- Third Arc Bio Inc., a clinical stage biotech company developing ... a potential best-in-class T cell engager targeting Claudin 6 (CLDN6). This Phase 1 study will ...

This Phase 1 study will evaluate the optimal dosing ... “ARC101 is the first program from our growing pipeline to reach the clinic – signifying Third Arc Bio’s transition into a clinical stage company ...